The purposes of acute toxicity testing are to obtain information on the biologic activity of a chemical and gain insight into its mechanism of action. The information on acute systemic toxicity generated by the test is used in hazard identification and risk management in the context of production, handling, and use of chemicals. The LD50 value, defined as the statistically derived dose that, when administered in an acute toxicity test, is expected to cause death in 50% of the treated animals in a given period, is currently the basis for toxicologic classification of chemicals.
Introduction
This paper gives a short review of methods for acute toxicity testing with the emphasis on the median lethal dose (LD50) test and alternative procedures that fulfill the requirement of reducing, refining, or replacing the use of animals in toxicity testing (the 3R principle). Furthermore, this review mirrors the current discussion on the usefulness of different procedures for acute toxicity testing and surveys the conclusions ofvarious panels, commissions, and groups.
Acute toxicity is usually defined as the adverse change(s) occurring immediately or a short time following a single or short period of exposure to a substance or substances or as adverse effects occurring within a short time of administration of a single dose of a substance or multiple doses given within 24 hr. An adverse effect is "any effect that results in functional impairment and/or biochemical lesions that may affect the performance of the whole organism or that reduce the organ's ability to respond to an additional challenge" (1) . Consequently, a chemical that enters the organism via the oral route during a restricted time and produces any adverse effect with little delay is orally and acutely toxic. However, the term acute oral toxicity is most often used in connection to lethality and LD50 determinations.
Studies of acute systemic toxicity attempt to determine the dose-dependent adverse effect that may occur and various appropriate data may be collected when determining the comprehensive acute toxicity profile of a substance. This may include the incidence of lethality. It has been claimed that when properly performed and closely observed, an acute toxicity test can give more information about the biologic properties of a chemical compound than any other single test, and even if the incidence of lethality were never computed as a consequence of such a test, one would only have lost a small proportion of the available information (2) . If the dosedependent lethality incidence is determined in a precise manner, it is usually expressed as an LD50. This is defined as the statistically derived dose that, when administered in an acute toxicity test, is expected to cause death in 50% of the treated animals in a given period (3) . For a classical LD50 study, laboratory mice and rats are species typically selected. Often the use of both sexes and a route of exposure anticipated to be the most probable route of exposure for humans are necessary for regulatory purposes. When oral administration is combined with parenteral, information on the bioavailability of the tested compound is obtained.
The purposes of acute toxicity testing are to obtain information on the biologic activity of a chemical and gain insight into its mechanism of action. Long-term studies usually start with a dose-finding exercise under acute conditions. Furthermore, the information on acute systemic toxicity generated by the test is used in hazard identification and risk management in the context of production, handling, and use of chemicals. The LD50 value (precise or approximate) is currently the basis for toxicologic classification of chemicals and is thus required by government authorities in different situations. The dosed animals are closely observed during the first 24 (15) and further reviewed by Seibert et al. (7) . In summary, the following scheme is proposed ( Figure 1 (17) , the procedure was incorporated into the OECD guidelines (guideline 420) in 1992 (9) . The results of the validation study showed a remarkable consistency between laboratories and it was concluded that the data generated could be used both for risk assessment and ranking chemicals for classification. Further evaluation of the method has proven its usefulness (18) (19) (20) (21) . The test substance is given at one of the four fixed-dose levels (5, 50, 500, and 2000 mg/kg) to five male and five female rats. The objective is to identify a dose that produces clear signs of toxicity but no mortality (22) . Depending on the results of the first test, either no further testing is needed or a higher or lower dose is tested: If mortality occurs, retesting at a lower dose level is necessary (except if the original dose chosen is 5 mg/kg). If no signs of toxicity occur at the initial dose, it is necessary to retest at a higher dose level. The results are thus interpreted in relation to animal survival and evident toxicity (5) and it becomes possible to assign the chemical to one of the OECD classification categories.
Toxic Class Method
The toxic dass method has been validated both nationally (23) and internationally (24) . The latter study included 20 (20, 25) .
Up-and-Down Method
In this type of procedure a single animal (or sometimes two to four animals) is exposed with subsequent doses adjusted up or down by a constant factor depending on the outcome of the previous dose (26) . If an animal dies during the initial step of the test, another animal is given a dose reduced by a factor of, e.g., 1.3. If this exposure does not result in toxicity, the dose is elevated by an equivalent constant factor until five animals have been dosed or the limit dose is reached. Although time consuming, the upand-down procedure can give good results with the use of as few as six to nine animals (18, 21) . Proposals are being circulated for acceptance of the up-and-down method into OECD guidelines (27) .
Predictive Power of Animal Tests for Human Toxicity
The problem of extrapolation of animal data to humans is well recognized (28) . According to Garattini (29) Figure 2A ), whereas mouse LD50 values correlated somewhat better (r2 = 0.65; Figure 2B ) (30, 31) .
The relationship between body weight, body surface area, specific surface area, and/or basal metabolic rate and oral LD50 has been investigated in several studies. It is evident that the predictive power of animal LD50 determinations for human toxicity can be improved if these parameters are accounted for in the extrapolation model [reviewed by Rhodes et al. (1)].
Cytotoxicity Determinations
In many investigations attempts have been made to find a correlation between simple cytotoxicity determinations in vitro and animal LD50 for many chemicals.
Despite the fact that such a relationship seems unlikely, many reports claim to have established a good correlation (e.g., [32] [33] [34] [35] Figure 1 ). The neurotoxicity of compounds that penetrate the blood-brain barrier is an important determinant of the final acute toxicity. A number of in vitro models for determining the ability of chemicals to penetrate the blood-brain barrier are available (37) . Furthermore, the conclusions and recommendations from the ECVAM Workshop on In Vitro Neurotoxicity Testing (38) should be considered in the development of alternative methods for testing of acute toxicity. The main suggestions in this report (38) In summary, it is obvious that significant progress is being made toward the understanding of the different components that constitute the complex events designated acute systemic toxicity. This understanding is required for the appropriate modeling of the different toxicologic elements and therefore is a prerequisite for the development of alternative methods that do not involve laboratory animals. It is also recognized that a single in vitro test cannot replace the dassical LD50 test or its animalbased alternatives. Tiered testing schemes seem to represent the solution to the problem and such schemes should therefore be developed, refined, optimized, and validated; when (or if) found to perform as necessary, they should be implemented in regulatory work.
